A Study for Long-term Follow-up of Hemophagocytic Lymphohistiocytosis (HLH) Participants Who Received Treatment With Emapalumab (NI-0501), an Anti-interferon Gamma Monoclonal Antibody
A Multicenter Study for the Long-term Follow-up of HLH Patients Who Received Treatment With NI-0501, an Anti-interferon Gamma Monoclonal Antibody
Sponsor: Seventh Framework Programme
A PHASE2/PHASE3 clinical study on Hemophagocytic Lymphohistiocytosis, this trial is completed. The trial is conducted by Seventh Framework Programme and has accumulated 20 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
20 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE2/PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Jul 2022 — Jul 2024 [monthly]
Completed PHASE2_PHASE3
Phase: NA → PHASE2_PHASE3
-
Sep 2021 — Jul 2022 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
▶ Show 15 earlier versions
-
Feb 2021 — Sep 2021 [monthly]
Active Not Recruiting NA
-
Jan 2021 — Feb 2021 [monthly]
Active Not Recruiting NA
-
Nov 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jul 2020 — Nov 2020 [monthly]
Recruiting NA
-
Nov 2019 — Jul 2020 [monthly]
Recruiting NA
-
Oct 2019 — Nov 2019 [monthly]
Recruiting NA
-
Sep 2019 — Oct 2019 [monthly]
Recruiting NA
-
Jul 2019 — Sep 2019 [monthly]
Recruiting NA
-
Jun 2019 — Jul 2019 [monthly]
Recruiting NA
-
Mar 2019 — Jun 2019 [monthly]
Recruiting NA
-
Jun 2018 — Mar 2019 [monthly]
Recruiting NA
-
Apr 2018 — Jun 2018 [monthly]
Recruiting NA
-
Jul 2017 — Apr 2018 [monthly]
Recruiting NA
-
Feb 2017 — Jul 2017 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Aug 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Seventh Framework Programme
- Swedish Orphan Biovitrum
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Barcelona, Spain , Chapel Hill, United States , Cincinnati, United States , Grand Rapids, United States , Houston, United States , London, United Kingdom , Madrid, Spain , Monza, Italy , Padua, Italy , Paris, France and 2 more locations